Table 4.
Comparison Three: Octenidine Compared to Saline for Chronic Wound Care | |||||
---|---|---|---|---|---|
Patient or Population: Chronic Wound Care Intervention: Octenidine Comparison: Saline | |||||
Outcomes | Anticipated Absolute Effects * (95% CI) | Relative Effect (95% CI) | № of Participants (Studies) | Certainty of the Evidence (GRADE) | |
Risk with Saline | Risk with Octenidine | ||||
Wound healing assessed with: Proportion of patients with complete wound healing follow-up: mean 12 weeks | 242 per 1000 | 250 per 1000 (136 to 461) |
RR 1.0313 (0.5595 to 1.9009) |
126 (1 RCT) |
⨁⨁⨁⨁ HIGH |
Adverse events assessed with: AE report follow-up: mean 12 weeks | 317 per 1000 | 178 per 1000 (90 to 351) |
RR 0.5614 (0.2844 to 1.1081) |
120 (1 RCT) |
⨁⨁⨁⨁ HIGH |
Healing rate assessed with: planimetry follow-up: mean 12 weeks | No difference in the healing rate of the patients in the octenidine group, compared to patients in the saline group (37.9% vs. 40.3%; p = 0.769) [29]. | (1 RCT) | ⨁⨁⨁⨁ HIGH |
||
Pain assessment—not measured | Not reported | - | - | ||
GRADE Working Group grades of evidence ⨁⨁⨁⨁ High certainty: We are very confident that the true effect lies close to that of the estimate of the effect. ⨁⨁⨁ Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. ⨁⨁ Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect. ⨁ Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. |
* The risk in the intervention group (and 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and 95% CI). CI: confidence interval; RR: risk ratio; RCT: randomised controlled trial.